Abstract
Prostate low dose rate (LDR) brachytherapy is a well-established standard of care treatment option for men with localized prostate cancer, with long-term follow-up and outcome data available. Image guidance is crucial for high-quality brachytherapy. Ongoing development and research are underway to incorporate more advanced imaging techniques into the procedure to enhance the quality and minimize the side effects of treatment. This chapter will discuss the history, rationale, and anatomy related to prostate brachytherapy. It also covers the various brachytherapy workflow steps involving the traditional computed tomography (CT) and ultrasound (US) imaging-directed brachytherapy and more recent advancements in incorporating magnetic resonance imaging (MRI) into the procedure.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Deming CL (1922) Results in one hundred cases of cancer of prostate and seminal vesicles, treated with radium surgery. Gynecol Obstet 34:99–118
Young HH (1917) The use of radium and the punch operation in desperate cases of enlarged prostate. Ann Surg 65:633
Flocks RH (1964) Interstitial irradiation therapy with a solution of AU198 as part of combination therapy for prostatic carcinoma. J Nucl Med 5:691–705
Charyulu KK (1980) Transperineal interstitial implantation of prostate cancer: a new method. Int J Radiat Oncol Biol Phys 6(9):1261–1266
NCCN Clinical Practice Guidlines in Oncology: Prostate Cancer V4.2018
Abu-Gheida I, Fleming C, Ramia P, Mian O, Tendulkar R, Ciezki J (2017) Current controversies in prostate brachytherapy for prostate cancer. Appl Radiat Oncol 6:6–11
Georg D, Hopfgartner J, Gora J, Kuess P, Kragl G, Berger D et al (2014) Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 88(3):715–722
Bruner DW, Moughan J, Prestidge BR, Sanda MG, Bice W, Michalski JM et al (2018) Patient reported outcomes of NRG Oncology/RTOG 0232: a phase III study comparing combined external beam radiation and transperineal interstitial permanent brachytherapy with brachytherapy alone in intermediate risk prostate cancer. Int J Radiat Oncol Biol Phys 102(3):S2–S3
Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ et al (2018) Prospective phase 2 trial of permanent seed implantation prostate brachytherapy for intermediate-risk localized prostate cancer: efficacy, toxicity, and quality of life outcomes. Int J Radiat Oncol Biol Phys 100(2):374–382
Prestidge BR, Winter K, Sanda MG, Amin M, Bice WS Jr, Michalski J et al (2016) Initial report of NRG Oncology/RTOG 0232: a phase 3 study comparing combined external beam radiation and transperineal interstitial permanent brachytherapy with brachytherapy alone for selected patients with intermediate-risk prostatic carcinoma. Int J Radiat Oncol Biol Phys 96(2):S4
Morris WJ, Tyldesley S, Rodda S, Halperin R, Pai H, McKenzie M et al (2017) Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): an analysis of survival endpoints for a randomized trial comparing a low-dose-rate brachytherapy boost to a dose-escalated external beam boost for high- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 98(2):275–285
Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL et al (2018) Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9–10 prostate cancer. JAMA 319(9):896–905
Frank SJ, Stafford RJ, Bankson JA, Li C, Swanson DA, Kudchadker RJ, Martirosyan KS (2008) A novel marker for prostate brachytherapy. Int J Radiat Oncol Biol Phys 71(1):5–8. https://doi.org/10.1016/j.ijrobp.2008.01.028
Wang J, Tanderup K, Cunha A, Damato AL, Cohen GN, Kudchadker RJ et al (2017) Magnetic resonance imaging basics for the prostate brachytherapist. Brachytherapy 16(4):715–727
Albert JM, Swanson DA, Pugh TJ et al (2013) Magnetic resonance imaging-based treatment planning for prostate brachytherapy. Brachytherapy 12(1):30–37. https://doi.org/10.1016/j.brachy.2012.03.009
Blanchard P, Ménard C, Frank SJ (2017) Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow. Brachytherapy 16(4):734–742. https://doi.org/10.1016/j.brachy.2016.11.012
Frank SJ, Mourtada F, Crook J, Ménard C (2017) Use of magnetic resonance imaging in low-dose-rate and high-dose-rate prostate brachytherapy from diagnosis to treatment assessment: defining the knowledge gaps, technical challenges, and barriers to implementation. Brachytherapy 16(4):672–678. https://doi.org/10.1016/j.brachy.2017.01.014
Crook JM, Tang C, Thames H et al (2020) A biochemical definition of cure after brachytherapy for prostate cancer. Radiother Oncol 149:64–69. https://doi.org/10.1016/j.radonc.2020.04.038
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Abu-Gheida, I., Moreno, A.C., Tang, C., Kudchadker, R., Wang, J., Frank, S.J. (2021). Low Dose Rate Brachytherapy: Uses and Advanced MRI Techniques in Prostate Cancer. In: Solanki, A.A., Chen, R.C. (eds) Radiation Therapy for Genitourinary Malignancies . Practical Guides in Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-65137-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-65137-4_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-65136-7
Online ISBN: 978-3-030-65137-4
eBook Packages: MedicineMedicine (R0)